모메타손 푸로에이트 시장 : 제형별, 적응증별, 투여 경로별, 유통 채널별, 지역별

Mometasone Furoate Market is estimated to be valued at USD 1,582.6 Mn in 2026 and is expected to reach USD 2,608.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033.

Mometasone furoate topical is effective at reducing the redness, itching, swelling, and other pain caused by several skin conditions. Mometasone furoate is a corticosteroid drug also used to treat asthma and it is an effective treatment for a variety of skin allergies as well as other allergic conditions like hay fever and allergic rhinitis.

Market Dynamics

Increasing prevalence of asthma worldwide is expected to witness significant growth in forecast period. For instance, according to the World Health Organization (WHO), in 2019, 455 000 individuals died from asthma and an estimated 262 million people were affected by asthma worldwide. Asthma is widely misdiagnosed and poorly managed, particularly in low- and middle-income countries. In most severe cases, asthma can be fatal.

Increasing product launches and approvals by market players are expected to drive growth of the global mometasone furoate market over the forecast period. For instance, in April 2017, Amneal Pharmaceuticals LLC, a U.S.-based, publicly traded generics and specialty pharmaceutical company launched Mometasone furoate nasal spray, the first pharmaceutical product that Amneal Pharmaceuticals LLC had produced in spray form. Nasonex is therapeutic equivalent of mometasone furoate and is offered in 50 mcg/spray strength.

Increasing research and development activities related to mometasone furoate are expected to drive growth of market over the forecast period. For instance, according to an article published in Medicine, medical journal, in December 2019, a study was performed on patients with head and neck squamous cell carcinoma (HNSCC) to check efficacy of local application of mometasone furoate in reducing acute radiation dermatitis (ARD) in China. Patients were divided into two groups, test groups and control groups. The patients in test groups were given mometasone furoate once daily from the start of their radiotherapy until the test side skin acquired ARD lesions, and patients in control groups, were given no treatment at all. The study showed that, mometasone furoate inunction after high dose radiotherapy can prevent acute radiation dermatitis (ARD).

Key features of the study

• This report provides an in-depth analysis of the global mometasone furoate market, market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains an attractive investment proposition matrix for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global mometasone furoate market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
• Key companies covered as a part of this study include include Cipla, Teva Pharmaceuticals, Glenmark Pharmaceuticals, AdvaCare Pharma, Medlab Pharmaceuticals Private Limited, Dermocare Laboratories, Iva Healthcare Private Limited, Unilab Chemicals & Pharmaceuticals Pvt Ltd, Organon group of companies, Cosette Pharmaceuticals, Taro Pharmaceutical Industries Ltd., and Hikma Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make an informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
• The global mometasone furoate market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global mometasone furoate market

Market Segmentation

• Global Mometasone Furoate Market, By Dosage form
  • Nasal Spray
  • Cream
  • Ointment
  • Inhalers
  • Others (Topical Solutions, etc.)
• Global Mometasone Furoate Market, By Indication
  • Inflammatory Skin Disorders
  • Asthma
  • Allergic rhinitis
  • Others (Hay Fever, etc.)
• Global Mometasone Furoate Market, By Route of Administration
  • Nasal Administration
  • Topical
  • Oral
• Global Mometasone Furoate Market, By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Mometasone Furoate Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Global Mometasone Furoate Market, Key Players
  • Cipla
  • Teva Pharmaceuticals
  • Glenmark Pharmaceuticals
  • AdvaCare Pharma
  • Medlab Pharmaceuticals Private Limited
  • Dermocare Laboratories
  • Iva Healthcare Private Limited
  • Unilab Chemicals & Pharmaceuticals Pvt Ltd
  • Organon group of companies
  • Cosette Pharmaceuticals
  • Taro Pharmaceutical Industries Ltd.
  • Hikma Pharmaceuticals.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Dosage form
  • Market Snippet, By Indication
  • Market Snippet, By Route of Administration
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Porter's Analysis
• Industry Trends
• Key Highlights
• Epidemiology
• Reimbursement Scenario
• Regulatory Scenario
• Product Launch and Approvals
• Acquisition and Collaboration Scenario

4. Global Mometasone Furoate Market, By Dosage Form, 2026-2033 (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026-2033
  • Segment Trends
• Nasal spray
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Cream
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Ointment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Inhalers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Mometasone Furoate Market, By Indication, 2026-2033 (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026-2033
  • Segment Trends
• Inflammatory skin disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Asthma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Allergic rhinitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Mometasone Furoate Market, By Route of Administration, 2026-2033 (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026-2033
  • Segment Trends
• Nasal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Global Mometasone Furoate Market, By Distribution Channel, 2026-2033 (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026-2033
  • Segment Trends
• Hospitals Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

8. Global Mometasone Furoate Market, By Region, 2026-2033 (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2026-2033
  • Regional Trends
• North America
  • Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033 (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033 (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033 (USD Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033 (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033 (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
  • Market Size and Forecast, By Country/Region, 2026-2033 (USD Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

• Company Profiles
  • Cipla
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Teva Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Glenmark Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • AdvaCare Pharma
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Medlab Pharmaceuticals Private Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Dermocare Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Iva Healthcare Private Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Unilab Chemicals & Pharmaceuticals Pvt Ltd
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Organon group of companies
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Cosette Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Taro Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Hikma Pharmaceuticals.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Analyst Views

10. Section

• Research Methodology
• About us
• Contact